Shots: The P-III MOUNTAIN study involves assessing of SAGE-217 (20/ 30mg) vs PBO in 581 patients with MDD The P-III MOUNTAIN study results: did not meet its 1EP i.e, reduction […]readmore
Tags : Major Depressive Disorders
Shots: The P-III RAP-MD (01,02,03,04) studies involve assessing of Rapastinel (450mg, 225mg) vs PBO as an adjunctive treatment of MDD The P-III RAP-MD-04 study demonstrated unmet 1EPs & 2EPs. RAP-MD […]readmore